Cambridge Investment Research Advisors, Inc. - BLACKROCK HEALTH SCIENCES TR ownership

BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 63 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of BLACKROCK HEALTH SCIENCES TR
ValueSharesWeighting
Q3 2023$1,946
-2.3%
49,696
+1.4%
0.01%0.0%
Q2 2023$1,992
-4.1%
49,014
-1.3%
0.01%
-10.0%
Q1 2023$2,078
-7.0%
49,635
-3.2%
0.01%
-16.7%
Q4 2022$2,234
-99.9%
51,258
-5.2%
0.01%0.0%
Q3 2022$2,098,000
-12.2%
54,044
-4.1%
0.01%
-7.7%
Q2 2022$2,389,000
-7.6%
56,352
-0.8%
0.01%
+8.3%
Q1 2022$2,586,000
-3.0%
56,818
+3.4%
0.01%0.0%
Q4 2021$2,666,000
+2.2%
54,966
+0.4%
0.01%
-7.7%
Q3 2021$2,609,000
+18.3%
54,744
+20.3%
0.01%
+18.2%
Q2 2021$2,206,000
+21.3%
45,489
+15.7%
0.01%
+10.0%
Q1 2021$1,818,000
-0.7%
39,308
+2.2%
0.01%
-9.1%
Q4 2020$1,830,000
+22.0%
38,448
+9.8%
0.01%
+10.0%
Q3 2020$1,500,000
+4.0%
35,005
-1.1%
0.01%
-9.1%
Q2 2020$1,443,000
+25.4%
35,385
+10.8%
0.01%0.0%
Q1 2020$1,151,000
-9.5%
31,927
+6.7%
0.01%
+10.0%
Q4 2019$1,272,000
+30.2%
29,921
+17.1%
0.01%
+11.1%
Q3 2019$977,000
+5.1%
25,545
+6.8%
0.01%0.0%
Q2 2019$930,000
+13.0%
23,913
+15.5%
0.01%
+12.5%
Q1 2019$823,000
+14.1%
20,695
+4.6%
0.01%0.0%
Q4 2018$721,000
-13.0%
19,784
+1.5%
0.01%0.0%
Q3 2018$829,000
+69.9%
19,493
+54.0%
0.01%
+60.0%
Q2 2018$488,000
+66.0%
12,656
+50.7%
0.01%
+66.7%
Q1 2018$294,000
+38.0%
8,397
+51.4%
0.00%
-50.0%
Q3 2014$213,0005,5450.01%
Other shareholders
BLACKROCK HEALTH SCIENCES TR shareholders Q2 2022
NameSharesValueWeighting ↓
Ahrens Investment Partners LLC 74,825$3,561,0001.91%
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 40,961$1,174,0000.99%
Diversified, LLC 19,077$818,0000.70%
CORRADO ADVISORS, LLC 9,645$459,0000.35%
Rikoon Group, LLC 16,672$793,0000.22%
Eudaimonia Partners, LLC 8,240$392,0000.09%
Arete Wealth Advisors, LLC 10,658$507,0000.07%
SOA Wealth Advisors, LLC. 4,900$242,0000.07%
Financial Advantage, Inc. 833$39,0000.04%
Jacobi Capital Management LLC 4,184$199,0000.03%
View complete list of BLACKROCK HEALTH SCIENCES TR shareholders